Background Mortality rates of coronavirus disease-2019 (COVID-19) continue to rise across
the world. The impact of several risk factors on coronavirus mortality has been previously …

Background The proportion of patients infected with SARS-CoV-2 that are prescribed
antibiotics is uncertain, and may contribute to patient harm and global antibiotic resistance …

In December 2019, a novel coronavirus was isolated from the respiratory epithelium of
patients with unexplained pneumonia in Wuhan, China. This pathogen, named severe acute …

The new respiratory infectious disease coronavirus disease 2019 (COVID-19) that
originated in Wuhan, China, in December 2019 and caused by a new strain of zoonotic …

Abstract Currently, coronavirus disease 2019 (COVID-19) is spreading rapidly around the
world. This study aimed to investigate whether the presence of acute kidney injury (AKI) …

Background COVID-19 has infected millions of people worldwide and is responsible for
several hundred thousand fatalities. The COVID-19 pandemic has necessitated thoughtful …

Background: coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome—coronavirus-2 (SARS-CoV-2)—is an ongoing pandemic with high morbidity and …

Background: Critically ill patients with COVID-19 may develop multiple organ dysfunction
syndrome, including acute kidney injury (AKI). We report the incidence, risk factors …

Kidneys are one of the targets for SARS-CoV-2, it is reported that up to 36% of patients with
SARS-CoV-2 infection would develop into acute kidney injury (AKI). AKI is associated with …

Previous studies have shown that common comorbidities were significantly associated with
the increased risk of adverse outcomes in patients with coronavirus disease 2019 (COVID …